Revenue Growth
Sales increased approximately 7% year over year in Q1 2026, driven by ~6% volume growth and ~1% favorable pricing.
Volume and Pricing Mix Improvements
Volume growth was primarily driven by chemical intermediates; market-based pricing improved ~3% (driven by plant nutrients) while raw-material pass-through pricing decreased ~2% due to lower benzene and propylene costs.
Operational Performance Gains
Sequential improvement in resin volumes and operational performance in Nylon Solutions and opportunistic spot sales in chemical intermediates supported higher sales volume sequentially.
Capital Allocation Discipline
Maintaining full-year capital expenditure guidance of $75 million to $95 million with ~20% targeted toward high-return growth investments and continued focus on cost productivity and turnaround execution.
DEF Expansion Opportunity
Entered a process design and licensing agreement to assess expansion of integrated ammonia platform at Hopewell to supply DEF; final investment decision targeted for 2027 with potential commercial startup in 2029 and internal hurdle rates of 20%+ IRR.
Strong Fertilizer Season Positioning
Domestic granular fertilizer sales expected to be near record levels (but closer to flat YoY); company maximizing ammonia availability for direct application and can moderate ammonium sulfate production as needed.
Expected Cash and Earnings Improvement
Management expects significant sequential earnings and cash flow improvement into Q2 and anticipates the second half of 2026 to be a source of cash to meet full-year expectations.
Section 45Q Carbon Capture Tax Credit Progress
IRS audit field work for 2018–2020 credits is underway with field work expected to wrap in Q2; management expects approximately $18 million of remaining proceeds (of a $20M total less $2M received) in the second half of 2026, subject to approval.